La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

National Research Croissance future

Future contrôle des critères 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for National Research.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Healthcare croissance des bénéfices	19.4%
Taux de croissance des recettes	n/a
Rendement futur des capitaux propres	n/a
Couverture par les analystes	None
Dernière mise à jour	n/a

Mises à jour récentes de la croissance future

Pas de mise à jour

Recent updates

National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12

Jun 19

National Research Corporation's (NASDAQ:NRC) Shares May Have Run Too Fast Too Soon

Jun 04

Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

Oct 01

We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt

Jul 10

Why We Like The Returns At National Research (NASDAQ:NRC)

May 04

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

Mar 25

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

Nov 17

National Research Corp: Market Is Discounting These Key Factors

Sep 18

National Research declares $0.24 dividend

Aug 23

National Research GAAP EPS of $0.33, revenue of $37.3M

Aug 02

National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively

Jul 13

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

May 27

National Research Corp.: Quality/Low Risk On Sale

May 17

The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested

Mar 21

National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

Feb 11

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme National Research n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

NasdaqGS:NRC - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
6/30/2024	146	29	23	40	N/A
3/31/2024	147	30	26	42	N/A
12/31/2023	149	31	22	38	N/A
9/30/2023	149	29	21	35	N/A
6/30/2023	148	29	21	35	N/A
3/31/2023	150	30	25	36	N/A
12/31/2022	152	32	26	36	N/A
9/30/2022	152	35	31	40	N/A
6/30/2022	152	36	32	39	N/A
3/31/2022	151	37	33	40	N/A
12/31/2021	148	37	41	46	N/A
9/30/2021	144	36	45	50	N/A
6/30/2021	140	36	47	52	N/A
3/31/2021	135	35	45	50	N/A
12/31/2020	133	37	37	41	N/A
9/30/2020	131	38	33	36	N/A
6/30/2020	130	36	35	39	N/A
3/31/2020	130	36	35	39	N/A
12/31/2019	128	32	36	41	N/A
9/30/2019	126	31	38	43	N/A
6/30/2019	124	30	32	38	N/A
3/31/2019	120	31	33	39	N/A
12/31/2018	120	30	34	40	N/A
9/30/2018	119	29	26	33	N/A
6/30/2018	118	26	31	36	N/A
3/31/2018	118	24	N/A	28	N/A
12/31/2017	118	23	N/A	28	N/A
9/30/2017	116	22	N/A	30	N/A
6/30/2017	114	23	N/A	26	N/A
3/31/2017	112	21	N/A	31	N/A
12/31/2016	109	20	N/A	27	N/A
9/30/2016	107	21	N/A	25	N/A
6/30/2016	106	20	N/A	24	N/A
3/31/2016	104	19	N/A	25	N/A
12/31/2015	102	17	N/A	22	N/A
9/30/2015	101	16	N/A	20	N/A
6/30/2015	100	16	N/A	24	N/A
3/31/2015	99	16	N/A	23	N/A
12/31/2014	99	18	N/A	26	N/A
9/30/2014	97	18	N/A	25	N/A
6/30/2014	95	17	N/A	25	N/A
3/31/2014	94	16	N/A	21	N/A
12/31/2013	93	15	N/A	19	N/A
9/30/2013	92	15	N/A	21	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if NRC's forecast earnings growth is above the savings rate (2.5%).

Bénéfices vs marché: Insufficient data to determine if NRC's earnings are forecast to grow faster than the US market

Croissance élevée des bénéfices: Insufficient data to determine if NRC's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: Insufficient data to determine if NRC's revenue is forecast to grow faster than the US market.

Croissance élevée des revenus: Insufficient data to determine if NRC's revenue is forecast to grow faster than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Insufficient data to determine if NRC's Return on Equity is forecast to be high in 3 years time

National Research Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Recent updates

Dividend of US$0.12 announced

Second quarter 2024 earnings released: EPS: US$0.26 (vs US$0.30 in 2Q 2023)

National Research Corporation (NasdaqGS:NRC) acquired Nobl, Inc. for $7 million.

National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12

National Research Corporation's (NASDAQ:NRC) Shares May Have Run Too Fast Too Soon

Now 22% undervalued after recent price drop

Dividend of US$0.12 announced

Estimating The Fair Value Of National Research Corporation (NASDAQ:NRC)

First quarter 2024 earnings released: EPS: US$0.27 (vs US$0.28 in 1Q 2023)

National Research Corporation Declares a Quarterly Cash Dividend, Payable on July 15, 2024

National Research Corporation to Report Q1, 2024 Results on May 07, 2024

National Research Corporation, Annual General Meeting, May 08, 2024

Jennifer Baron Joins NRC Health as Its First Chief Experience Officer

Upcoming dividend of US$0.12 per share

Full year 2023 earnings released: EPS: US$1.26 (vs US$1.28 in FY 2022)

National Research's (NASDAQ:NRC) Dividend Will Be $0.12

Dividend of US$0.12 announced

National Research Corporation Announces the Retirement of Kevin Karas as Chief Financial Officer, Effective March 31, 2024

Full year 2023 earnings released: EPS: US$1.26 (vs US$1.28 in FY 2022)

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 15, 2024

National Research Corporation to Report Q4, 2023 Results on Feb 13, 2024

National Research Corporation Announces Executive Appointments

Insider recently sold US$15m worth of stock

Upcoming dividend of US$0.12 per share at 1.2% yield

Founder recently sold US$2.3m worth of stock

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

New minor risk - Insider selling

National Research Corporation Declares Quarterly Dividend, Payable on January 12, 2024

Founder notifies of intention to sell stock

Third quarter 2023 earnings released: EPS: US$0.32 (vs US$0.34 in 3Q 2022)

National Research Corporation to Report Q3, 2023 Results on Nov 07, 2023

Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

Upcoming dividend of US$0.12 per share at 1.0% yield

Upcoming dividend of US$1.00 per share at 1.1% yield

National Research Corporation Declares Special Dividend, Payable on September 22, 2023

National Research Corporation Declares Quarterly Dividend, Payable on October 13, 2023

Second quarter 2023 earnings released: EPS: US$0.30 (vs US$0.33 in 2Q 2022)

National Research Corporation to Report Q2, 2023 Results on Aug 01, 2023

We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt

Upcoming dividend of US$0.12 per share at 1.9% yield

Founder recently sold US$1.5m worth of stock

Founder recently sold US$954k worth of stock

Founder recently sold US$1.3m worth of stock

National Research Corporation Declares Quarterly Dividend, Payable on July 14, 2023

Why We Like The Returns At National Research (NASDAQ:NRC)

First quarter 2023 earnings released: EPS: US$0.28 (vs US$0.34 in 1Q 2022)

Founder recently sold US$59k worth of stock

Chief Operating Officer recently sold US$1.1m worth of stock

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

Upcoming dividend of US$0.12 per share at 1.9% yield

Senior VP of Finance recently sold US$544k worth of stock

Founder recently sold US$292k worth of stock

Full year 2022 earnings released: EPS: US$1.28 (vs US$1.47 in FY 2021)

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 14, 2023

National Research Corporation to Report Q4, 2022 Results on Feb 14, 2023

Founder recently sold US$259k worth of stock

Founder exercised options to buy US$439k worth of stock.

Upcoming dividend of US$0.12 per share

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

National Research Corporation Declares Quarterly Dividend, Payable on January 13, 2023

Third quarter 2022 earnings released: EPS: US$0.34 (vs US$0.38 in 3Q 2021)

Founder recently sold US$1.8m worth of stock

Founder recently sold US$1.8m worth of stock

Chief Operating Officer exercised options and sold US$339k worth of stock

Upcoming dividend of US$0.24 per share

National Research Corp: Market Is Discounting These Key Factors

Founder recently sold US$3.9m worth of stock

National Research Corporation Declares Quarterly Dividend, Payable on October 14, 2022

National Research declares $0.24 dividend

Now 20% undervalued

National Research GAAP EPS of $0.33, revenue of $37.3M

National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively

Upcoming dividend of US$0.24 per share

Founder recently sold US$8.9m worth of stock

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?